CSPC Pharmaceutical Group Limited
(Incorporated in Hong Kong with limited liability)

Announcements & Notices       

2022-December-29	VOLUNTARY ANNOUNCEMENT - ALMB-0166 FOR THE TREATMENT OF OSTEOARTHRITIS OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2022-December-28	VOLUNTARY ANNOUNCEMENT - ORAL SMALL-MOLECULE CDK INHIBITOR SYH2043 OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2022-December-22	VOLUNTARY ANNOUNCEMENT - NBL-020 FOR THE TREATMENT OF ADVANCED SOLID TUMORS OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
2022-December-7	VOLUNTARY ANNOUNCEMENT - ORAL SMALL-MOLECULE 3CLpro INHIBITOR SYH2055 AGAINST SAR-CoV-2 OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2022-November-29	VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE CPO204 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
2022-November-23	VOLUNTARY ANNOUNCEMENT - "SYHX1901 TABLETS" OBTAINS CLINICAL TRIAL APPROVAL FOR THE TREATMENT OF SEVERE COVID-19 (in PDF)
2022-November-23	QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2022 (in PDF)
2022-November-16	VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW INDICATION APPLICATION FOR MARKETING APPROVAL OF MINGFULE (RECOMBINANT HUMAN TNK TISSUE-TYPE PLASMINOGEN ACTIVATOR FOR INJECTION) (in PDF)
2022-November-11	DATE OF BOARD MEETING (in PDF)
2022-November-10	VOLUNTARY ANNOUNCEMENT - "ARGATROBAN INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-November-8	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2022-November-8	APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND COMPLIANCE WITH RULE 13.92 OF THE LISTING RULES (in PDF)
2022-October-28	DIVERSITY OF BOARD MEMBERS - NON-COMPLIANCE WITH RULE 13.92 OF THE LISTING RULES (in PDF)
2022-October-27	VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE "SYS6002" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2022-October-24	INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THIRD QUARTER OF 2022 (in PDF)
2022-October-24	VOLUNTARY ANNOUNCEMENT - "TOFACITINIB CITRATE EXTENDED-RELEASE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-October-10	VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH HARBOUR BIOMED (SHANGHAI) CO., LTD. FOR BATOCLIMAB (HBM9161) (in PDF)
2022-September-20	VOLUNTARY ANNOUNCEMENT - "LENALIDOMIDE CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-September-9	VOLUNTARY ANNOUNCEMENT - "TG103 INJECTION" OBTAINS CLINICAL TRIAL APPROVAL FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (in PDF)
2022-September-9	VOLUNTARY ANNOUNCEMENT - "TG103 INJECTION" OBTAINS CLINICAL TRIAL APPROVAL FOR THE TREATMENT OF ALZHEIMER'S DISEASE (in PDF)
2022-August-24	2022 INTERIM DIVIDEND (in PDF)
2022-August-24	2022 INTERIM RESULTS ANNOUNCEMENT (in PDF)
2022-August-23	VOLUNTARY ANNOUNCEMENT - UPDATE ON THE CLINICAL STUDY PROGRESS OF SARS-CoV-2 mRNA VACCINE (SYS6006) (in PDF)
2022-August-23	VOLUNTARY ANNOUNCEMENT - COMPLETION OF A CLINICAL STUDY OF HETEROLOGOUS BOOSTER IMMUNIZATION OF SARS-CoV-2 mRNA VACCINE (SYS6006) (in PDF)
2022-August-22	VOLUNTARY ANNOUNCEMENT - SELECTIVE NTRK AND ROS1 DUAL INHIBITOR "SYHX2009" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2022-August-22	VOLUNTARY ANNOUNCEMENT - CLASS 1 NEW DRUG "PRUSOGLIPTIN TABLETS" MEETS PREDEFINED ENDPOINTS IN THE PIVOTAL CLINICAL TRIALS FOR THE TREATMENT OF TYPE 2 DIABETES (in PDF)
2022-August-19	INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE HALF YEAR ENDED 30 JUNE 2022 (in PDF)
2022-August-19	VOLUNTARY ANNOUNCEMENT - "MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-August-18	VOLUNTARY ANNOUNCEMENT - DUOENDA (MITOXANTRONE HYDROCHLORIDE LIPOSOME INJECTION) OBTAINS CLINICAL TRIAL APPROVAL FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDERS (in PDF)
2022-August-12	DATE OF BOARD MEETING (in PDF)
2022-August-4	VOLUNTARY ANNOUNCEMENT - MINGFULE (RECOMBINANT HUMAN TNK TISSUE-TYPE PLASMINOGEN ACTIVATOR FOR INJECTION) MET PRIMARY ENDPOINT IN PHASE III STUDY FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE (in PDF)
2022-August-4	CHANGE OF ADDRESS OF SHARE REGISTRAR AND TRANSFER OFFICE (in PDF)
2022-August-1	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2022-August-1	RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR (in PDF)
2022-July-28	VOLUNTARY ANNOUNCEMENT - DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) GRANTED ORPHAN-DRUG DESIGNATION BY U.S. FDA FOR TREATMENT OF GASTRIC CANCER (in PDF)
2022-July-28	VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT FOR SYSA1801 WITH ELEVATION ONCOLOGY, INC. (in PDF)
2022-July-11	VOLUNTARY ANNOUNCEMENT - "LACOSAMIDE INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-July-11	VOLUNTARY ANNOUNCEMENT - "GABAPENTIN CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-June-24	CONNECTED TRANSACTIONS - LEASE AGREEMENTS (in PDF)
2022-June-22	VOLUNTARY ANNOUNCEMENT - BIOLOGIC LICENSE APPLICATION FOR JMT103 ACCEPTED BY THE NMPA (in PDF)
2022-June-13	VOLUNTARY ANNOUNCEMENT - "PRAMIPEXOLE DIHYDROCHLORIDE SUSTAINED-RELEASE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-May-30	VOLUNTARY ANNOUNCEMENT - "TENOFOVIR ALAFENAMIDE FUMARATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-May-27	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2022-May-27	APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE OF CHIEF EXECUTIVE OFFICER (in PDF)
2022-May-26	POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 26 MAY 2022 (in PDF)
2022-May-25	QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2022 (in PDF)
2022-May-18	VOLUNTARY ANNOUNCEMENT - "DOXOFYLLINE INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-May-13	DATE OF BOARD MEETING (in PDF)
2022-May-5	VOLUNTARY ANNOUNCEMENT - "DONEPEZIL HYDROCHLORIDE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-April-28	INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2022 (in PDF)
2022-April-26	VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE FGFR4 INHIBITOR "SYHX2005" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2022-April-22	VOLUNTARY ANNOUNCEMENT - "ESOMEPRAZOLE SODIUM FOR INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-April-22	VOLUNTARY ANNOUNCEMENT - "VORTIOXETINE HYDROBROMIDE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-April-22	VOLUNTARY ANNOUNCEMENT - "NIFEDIPINE CONTROLLED-RELEASE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-April-21	NOTICE OF ANNUAL GENERAL MEETING (in PDF)
2022-April-20	VOLUNTARY ANNOUNCEMENT - ANTI-TUMOR NANODRUG "CISPLATIN MICELLE INJECTION" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2022-April-3	VOLUNTARY ANNOUNCEMENT - COVID-19 mRNA VACCINE "SYS6006" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2022-March-22	CASH DIVIDEND ANNOUNCEMENT FOR EQUITY ISSUER (in PDF)
2022-March-22	ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021 (in PDF)
2022-March-21	VOLUNTARY ANNOUNCEMENT - CLASS 1 NEW DRUG JMT103 MEETS PRE-DEFINED ENDPOINTS IN THE PIVOTAL CLINICAL TRIAL FOR THE TREATMENT OF UNRESECTABLE OR SURGICALLY DIFFICULT GIANT CELL TUMOR OF BONE (in PDF)
2022-March-18	VOLUNTARY ANNOUNCEMENT - "DUVELISIB CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-March-17	INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2021 (in PDF)
2022-March-10	DATE OF BOARD MEETING (in PDF)
2022-February-8	VOLUNTARY ANNOUNCEMENT - ACQUISITION OF EQUITY INTEREST IN RECOMGEN BIOTECH (in PDF)
2022-February-7	VOLUNTARY ANNOUNCEMENT - ANTI-TUMOR NANODRUG "SYHA1908 FOR INJECTION" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2022-January-27	VOLUNTARY ANNOUNCEMENT - JMT601 (CPO107) GRANTED FAST TRACK DESIGNATION BY U.S. FDA FOR TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (in PDF)
2022-January-20	VOLUNTARY ANNOUNCEMENT - GRANT OF SHARE AWARDS TO SELECTED GRANTEES BY A SHAREHOLDER (in PDF)
2022-January-12	VOLUNTARY ANNOUNCEMENT - "LENVATINIB MESILATE CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-January-11	VOLUNTARY ANNOUNCEMENT - "MITOXANTRONE HYDROCHLORIDE LIPOSOME INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2022-January-10	VOLUNTARY ANNOUNCEMENT - "ZOLEDRONIC ACID INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2024	2024 Announcements & Notices
2023	2023 Announcements & Notices
2021	2021 Announcements & Notices
2020	2020 Announcements & Notices
2019	2019 Announcements & Notices
2018	2018 Announcements & Notices
2017	2017 Announcements & Notices
2016	2016 Announcements & Notices
2015	2015 Announcements & Notices
2014	2014 Announcements & Notices
2013	2013 Announcements & Notices
2012	2012 Announcements & Notices
2011	2011 Announcements & Notices
2010	2010 Announcements & Notices
2009	2009 Announcements & Notices
2008	2008 Announcements & Notices
2007	2007 Announcements & Notices
2006	2006 Announcements & Notices